111 Inc
YI7.395USD
-0.055-0.74%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
374.74MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über 111 Inc Unternehmen
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
111 Inc Informationen
BörsenkürzelYI
Name des Unternehmens111 Inc
IPO-datumSep 12, 2018
CEOLiu (Junling)
Anzahl der mitarbeiter1238
WertpapierartDepository Receipt
GeschäftsjahresendeSep 12
Addresse3-4/F, No.295 Zuchongzhi Road
StadtSHANGHAI
BörseNASDAQ OMX - NASDAQ BASIC
LandChina
Postleitzahl201203
Telefon862120536666
Websitehttp://corporate.111.com.cn/
BörsenkürzelYI
IPO-datumSep 12, 2018
CEOLiu (Junling)
Führungskräfte von 111 Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product Revenues
2.98B
99.44%
Service Revenues
16.89M
0.56%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product Revenues
2.98B
99.44%
Service Revenues
16.89M
0.56%
Aktionärsstatistik
Aktualisiert: Fri, Jan 30
Aktualisiert: Fri, Jan 30
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Serenus Wealth Advisors, LLC
0.09%
Andere
90.39%
Aktionäre
Aktionäre
Anteil
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Serenus Wealth Advisors, LLC
0.09%
Andere
90.39%
Aktionärstypen
Aktionäre
Anteil
Corporation
8.57%
Investment Advisor
0.68%
Hedge Fund
0.26%
Research Firm
0.10%
Investment Advisor/Hedge Fund
0.05%
Andere
90.33%
Institutionelle Beteiligung
Aktualisiert: Wed, Jan 21
Aktualisiert: Wed, Jan 21
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q4
25
52.21K
6.89%
--
2025Q4
37
55.41K
1.09%
-397.88K
2025Q3
42
1.21M
23.79%
-403.88K
2025Q2
48
1.99M
39.33%
-416.92K
2025Q1
49
2.00M
39.53%
-387.91K
2024Q4
51
2.26M
44.72%
+133.67K
2024Q3
43
1.99M
39.36%
-280.22K
2024Q2
45
2.17M
42.88%
-87.92K
2024Q1
52
2.15M
42.65%
-125.45K
2023Q4
54
2.16M
44.89%
-28.04K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
First Pharmacia International
434.53K
8.57%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
29.91K
0.59%
+15.14K
+102.54%
Sep 30, 2025
Renaissance Technologies LLC
13.01K
0.26%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
5.14K
0.1%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
2.44K
0.05%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
1.45K
0.03%
-4.67K
-76.32%
Sep 30, 2025
SBI Securities Co., Ltd.
184.00
0%
-40.00
-17.86%
Sep 30, 2025
J.P. Morgan Securities LLC
23.00
0%
+15.00
+187.50%
Sep 30, 2025
Parametric Portfolio Associates LLC
27.00
0%
--
--
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
SPDR S&P Emerging Markets Small Cap ETF
0%
SPDR Portfolio Emerging Markets ETF
0%
SPDR S&P Emerging Asia Pacific ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
Anteil0%
SPDR Portfolio Emerging Markets ETF
Anteil0%
SPDR S&P Emerging Asia Pacific ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Datum
Ex-Dividendentag
Art
Verhältnis
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
